Deferred Tax Assets, Valuation Allowance of KYNTRA BIO, INC. from 31 Dec 2014 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
KYNTRA BIO, INC. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2014 to 31 Dec 2024.
  • KYNTRA BIO, INC. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $452,740,000, a 6.2% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

KYNTRA BIO, INC. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $452,740,000 +$26,385,000 +6.2% 31 Dec 2024 10-K 17 Mar 2025 2024 FY
Q4 2023 $426,355,000 -$51,614,000 -11% 31 Dec 2023 10-K 17 Mar 2025 2024 FY
Q4 2022 $477,969,000 +$68,159,000 +17% 31 Dec 2022 10-K 26 Feb 2024 2023 FY
Q4 2021 $409,810,000 +$71,986,000 +21% 31 Dec 2021 10-K 27 Feb 2023 2022 FY
Q4 2020 $337,824,000 +$123,977,000 +58% 31 Dec 2020 10-K/A 04 Mar 2022 2021 FY
Q4 2019 $213,847,000 +$19,860,000 +10% 31 Dec 2019 10-K 01 Mar 2021 2020 FY
Q4 2018 $193,987,000 +$34,447,000 +22% 31 Dec 2018 10-K 02 Mar 2020 2019 FY
Q4 2017 $159,540,000 +$30,545,000 +24% 31 Dec 2017 10-K 27 Feb 2019 2018 FY
Q4 2016 $128,995,000 +$12,277,000 +11% 31 Dec 2016 10-K 27 Feb 2018 2017 FY
Q4 2015 $116,718,000 +$21,987,000 +23% 31 Dec 2015 10-K 01 Mar 2017 2016 FY
Q4 2014 $94,731,000 31 Dec 2014 10-K 29 Feb 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.